A Phase 1b, Multi-Center, Open-Label Study of Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-Cell Lymphoma: CC-122-DLBCL-001 Ribrag, V., Chavez, J. C., Kaplan, J. B., Vitolo, U., Chandler, J. C., Santoro, A., Corradini, P., Cassier, P., Flinn, I. W., Advani, R., Sangha, R., Isufi, I., Kenkre, V. P., Hagner, P. R., Trowe, T., Gandhi, A. K., Wu, X., Hege, K., Pourdehnad, M., Kuruvilla, J. AMER SOC HEMATOLOGY. 2016

View details for Web of Science ID 000394452500040